Flagship Ventures Opportunities Fund I General Partner LLC
CIK 0001725004
Director10% Owner
Filings
3
Latest Jan 15, 2026
Issuers covered
3
Showing
3 of 3
Page 1
Track record
5 of 8 open-market trades scored (63% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 100% | +4.7% | +4.7% | +4.7% | +4.7% |
| 90 days | 5 | 100% | +3.8% | +3.8% | +3.8% | +3.8% |
| 180 days | 5 | 0% | -4.7% | -4.7% | -4.7% | -4.7% |
| 365 days | 5 | 0% | -93.0% | -93.0% | -93.0% | -93.0% |
Issuers
Companies where Flagship Ventures Opportunities Fund I General Partner LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AXLA | Axcella Health Inc. | 1 | Mar 18, 2022 |
| EVLO | Evelo Biosciences, Inc. | 1 | Jun 1, 2022 |
| FHTX | Foghorn Therapeutics Inc. | 1 | Jan 15, 2026 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|